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Unanchored chains of ubiquitin have recently been proposed to play a role in signaling. In this issue of
Immunity, Jiang et al. (2012) demonstrate that binding of free polyubiquitin to the viral RNA sensors RIG-I
and MDA5 leads to their oligomerization and activation.The innate immune system constitutes
the first line of host defense against
invading pathogens. The detection of
pathogens involves recognition of path-
ogen-associated molecular patterns by
a variety of host pattern recognition
receptors. In the case of viral infection,
viral RNA is recognized in endosomes
by specific membrane-bound Toll-like
receptors (TLRs) and in the cytoplasm
by retinoic acid-inducible gene I (RIG-I)-
like receptors (RLRs), including RIG-I
and MDA5. RIG-I is indispensable for
expression of type I interferon (IFN-a
and IFN-b) in response to many single-
stranded RNA viruses, including influenza
A, Sendai virus, and hepatitis C virus.
Similarly, MDA5 is essential for protection
against a different set of viruses, including
picornaviruses such as poliovirus and
encephalomyocarditis virus (EMCV).
Stimulation of these viral RNA receptors
initiates a cascade of antiviral responses,
including the induction of type I IFN, acti-
vation of inflammasomes, and expression
of proinflammatory cytokines and chemo-
kines (Loo and Gale, 2011).
The N termini of RIG-I and MDA5 share
two caspase activation and recruitment
domains (CARDs), which mediate sig-
naling by binding to the CARD domain of
the adaptor protein MAVS at the outer
membranes of mitochondria. This sig-
naling promotes the activation of down-
stream kinases, including TBK1 and
IKKi. These kinases phosphorylate the
transcription factor interferon regulatory
factor 3 (IRF3), leading to its dimerization
and translocation to the nucleus, where
it drives expression of type I IFN. Ubiquiti-
nation of key components of the RLR
signaling pathway appears to be a major
point of regulation (Maelfait and Beyaert,
2012). Lysine 63 (K63) is one of the seven
lysine residues of ubiquitin through whichlinkage can give rise to polyubiquitin
chains (Verhelst et al., 2011). Recently,
the Chen lab revealed that binding of the
RIG-I CARD domains to free K63-linked
polyubiquitin chains, which are not conju-
gated to any cellular protein, is important
for the activation of IRF3 (Zeng et al.,
2010). However, whether MDA5 is acti-
vated by a similar mechanism and how
binding of unanchored polyubiquitin
leads to RIG-I and MDA5 activation
remained unresolved. In this issue of
Immunity, Jiang et al. (2012) from the
Chen lab demonstrate a unified role for
unanchored K63-linked polyubiquitin
chains in RIG-I and MDA5 activation
and reveal polyubiquitin-induced oligo-
merization as the underlying mechanism.
To study whether MDA5 is activated
by a mechanism resembling that of RIG-I
activation, Jiang et al. (2012) used their
previously established in vitro cell-free
system consisting of mitochondrial
extracts (as a source of MAVS) and cyto-
solic extracts (as a source of TBK1 and
IKKi kinases) (Zeng et al., 2010). They
showed that incubation of free K63-linked
chains containing four or more ubiquitin
molecules with a recombinant MDA5
fragment consisting of its two N-terminal
CARD domains [MDA5(N)] led to IRF3
activation. In contrast, when the authors
incubated MDA5(N) with preassembled
K48-linked chains or linear tetraubiquitin,
in which the N-terminal methionine of
one ubiquitin is conjugated to the C
terminus of the preceding ubiquitin, no
IRF3 activation was observed.
The N-terminal CARD domains of
full-length MDA5 are exposed only after
conformational changes induced by
binding of viral RNA to the C-terminal
RNA-binding domain and helicase
domains. In agreement with that, Jiang
et al. (2012) showed that incubation ofImmunityfull-length MDA5 with unanchored K63-
linked ubiquitin chains promoted IRF3
activation in the in vitro reconstitution
system only in the presence of a viral
RNA mimic. CARD domains belong to
the death domain superfamily, which
also includes the death domain, death
effector domain, and pyrin domain
subfamilies (Kersse et al., 2011). Jiang
et al. (2012) noted that neither the CARD
domains of MAVS, NOD1, and NOD2 nor
the death effector domains of caspase-8
bind K63 polyubiquitin chains, indicating
that ubiquitin binding is not a general
characteristic within the death domain
superfamily.
Unanchored ubiquitin chains are
thought to be rare in living cells. To deter-
mine whether MDA5 binds to endoge-
nous, unanchored, K63-linked polyubi-
quitin chains in cells, Jiang et al. (2012)
isolated polyubiquitin chains that copurify
with overexpressed MDA5(N) in mam-
malian cell extracts. To that end, they
used chemical deubiquitinase (DUB)
inactivation and selective thermal dena-
turation as previously described for
RIG-I(N) (Zeng et al., 2010). The superna-
tant of the MDA5(N) pull-down containing
the heat-resistant ubiquitin chains could
activate the IRF3 pathway when reintro-
duced into the cell-free system together
withMDA5(N). This activity was destroyed
by isopeptidase T and CYLD, which
cleave unanchored and K63-linked
polyubiquitin chains, respectively. Similar
results were obtained with the heat-
resistant supernatant of full-length MDA5
immunoprecipitated from cells trans-
fected with EMCV RNA. These data
collectively provide strong evidence for
unanchored K63-linked polyubiquitin
as the MDA5-activating component. The
origin and abundance of the unanchored
chains is still unclear. Ubiquitin chains36, June 29, 2012 ª2012 Elsevier Inc. 897
Figure 1. Model for RIG-I and MDA5 Activation by Viral RNA and Unanchored K63
Polyubiquitin
In the inactive state, the RIG-I (or MDA5) CARDs are sequestered by the helicase domains and are not
available for signaling. 50triphosphate viral RNA that has dsRNA structures is captured by the C-terminal
domain (CTD) and helicase domains together with ATP. Conformational changes upon RNA and ATP
binding push the tandem CARDs away from the helicase complex, making them available to recruit
K63 polyubiquitin, which leads to the formation of a large complex consisting of four RIG-I (MDA5) and
four polyubiquitin chains. This heterotetrameric complex then catalyzes the formation of prion-like aggre-
gates of MAVS and subsequent downstream signaling to IRF3 and type I IFN induction (not shown).
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Previewsmight first be conjugated to a target and
then removed by a DUB. Alternatively,
unanchored ubiquitin chains might be
abundantly present in a signaling complex
as part of the ubiquitination reaction itself.
Jiang et al. (2012) continued their inves-
tigation on the newly discovered role of
MDA5 CARDs by performing multiple
structure-function studies. Many muta-
tions in the CARDs of RIG-I and MDA5
that disrupt their binding to K63 polyubi-
quitin chains also impaired their ability to
activate IRF3 in the cell-free system or
upon reconstitution in RIG-I- or MDA5-
deficient cells infected with Sendai virus
or EMCV. RIG-I activation was previously
shown to induce prion-like aggregation of
the adaptor protein MAVS (Hou et al.,
2011). The RIG-I and MDA5 mutants
defective in K63 polyubiquitin binding
now also failed to induce MAVS aggrega-
tion upon incubation with mitochondrial
extracts. Taken together, these data
further demonstrate that the binding to
K63 polyubiquitin chains is of key impor-
tance for RIG-I and MDA5 to activate
IRF3.
Jiang et al. (2012) also address the
question of whether covalent modification
of RIG-I and MDA5 with ubiquitin has
a role in signaling. So far, there is no
evidence that MDA5 is ubiquitinated,
and DUB-mediated removal of ubiquitin
chains from RIG-I did not impair its ability898 Immunity 36, June 29, 2012 ª2012 Elsevto activate IRF3 (Zeng et al., 2010). Origi-
nally, TRIM25-mediated RIG-I ubiquitina-
tion at lysine 172 was suggested to be
crucial for RIG-I signaling (Gack et al.,
2007), but it was subsequently shown
that mutation of this residue also affects
binding to unanchored polyubiquitin
(Zeng et al., 2010). Now, the authors
elegantly demonstrate that the ability of
this ubiquitination-defective RIG-I mutant
to activate IRF3 in vitro or to induce IFN-
b in cells can be restored by fusing it to
a heterologous ubiquitin-binding domain
(NZF). This observation clearly demon-
strates that binding to unanchored polyu-
biquitin is essential for RIG-I and MDA5
signaling.
Another interesting finding in this work
is that polyubiquitin binding to RIG-I
results in its oligomerization. To under-
stand the underlying molecular mecha-
nism for the polyubiquitin-induced RIG-I
and MDA5 activation, Jiang et al. (2012)
performed gel filtration and sedimentation
velocity analytical centrifugation. These
studies show that incubation of RIG-I(N)
and MDA5(N) with K63-linked ubiquitin
chains of different lengths (3–6molecules)
caused the formation of larger complexes
that strongly activated IRF3 in vitro, but
incubation with monoubiquitin did not
produce this effect. Molar mass and stoi-
chiometry measurements revealed that
RIG-I CARD and polyubiquitin form het-ier Inc.eromeric complexes with a stoichiometry
of 4:4 irrespective of chain lengths. Simi-
larly, incubation of full-length RIG-I with
triphosphate-RNA and K63 polyubiquitin
induced RIG-I oligomerization. Jiang
et al. (2012) went on to show that RIG-I
also forms oligomers in cells infected
with Sendai virus in a polyubiquitin-
dependent manner by demonstrating
that Ubc13 depletion or expression of
polyubiquitin-binding deficient RIG-I
mutants prevented the formation of high-
molecular-weight (HMW) RIG-I com-
plexes capable of IRF3 activation. It
should be noted that only a small fraction
of RIG-I forms a HMW complex with poly-
ubiquitin, indicating that its formation
might be regulated by localization and
compartmentalization of all players within
the cell. In this context, it will also be
important to reveal the molecular com-
position of RIG-I complexes of different
size by in-depth mass spectrometry
analysis. The Chen lab previously also
reported the binding of free K63 polyubi-
quitin to the adaptor proteins TAB2 and
NEMO in the NF-kB signaling pathway
(Xia et al., 2009). We speculate that
ubiquitin-induced oligomerization could
turn out to be a more general concept in
immune signaling.
The findings of Jiang et al. (2012)
support a model in which sequential
binding of RIG-I to viral RNA and K63
polyubiquitin chains leads to its oligomer-
ization and subsequent activation (Fig-
ure 1). Modeling of human RIG-I CARDs
revealed that several of the inactivating
substitutions are mapped to the surface
of the second CARD or at the junction
between CARD1 and CARD2. Deter-
mining high-resolution crystal structures
will be important for definitive confirma-
tion of the model and for understanding
how ubiquitin chains bind to RIG-I CARD
domains and induce the specific forma-
tion of RIG-I tetramers. This might
also reveal whether polyubiquitin chains
function as a cross-linker between
different CARD domains or whether they
induce conformational changes that
promote intermolecular CARD interac-
tions. An even more compelling question
is how RIG-I oligomers activate MAVS
and induce its prion-like aggregation
(Hou et al., 2011). Jiang et al. (2012)
mention that they were unable to detect
a stable interaction between RIG-I and
MAVS, regardless of the presence of
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PreviewsK63 polyubiquitin chains. They propose
that the RIG-I polyubiquitin complex
acts like a catalyst that needs only a
transient interaction with MAVS. Such
a mechanism would allow a rapid and
strong immune response upon detection
of only a few virus particles. At the same
time, however, it raises the important
question of which mechanisms are in
place to revert such a robust immune
response in time in order to prevent the
immune system from going awry. In this
context, the identification and character-
ization of specific DUBs (in addition to iso-
peptidase-T) that control the amount ofunanchored polyubiquitin in the cell or in
specific signaling complexes will be
extremely important.REFERENCES
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In this issue of Immunity, Kageyama et al. (2012), Zhao et al. (2012), and Dong et al. (2012) show that the
adaptor protein SAP regulates both positive and negative signals through SLAM receptors to stabilize
intercellular contacts.The SAP (signaling lymphocytic activation
molecule-associated protein) family of
adapters plays critical roles in multiple
immune functions. The importance of
SAP in immune regulation was first under-
lined by the discovery that SAP ismutated
in cases of X-linked lymphoproliferative 1
(XLP1) disease, a human immunodefi-
ciency characterized by an abnormal re-
sponse to Epstein-Barr virus (EBV) infec-
tion. Upon infection, XLP1 patients fail
to clear EBV-infected B cells and dis-
play massive lymphoproliferation; XLP1
patients can also develop hypogamma-
globulinemia and malignant lymphomas.
Defects in the development and/or func-
tion of a large variety of immune cells
have been reported in SAP-deficient
XLP patients, as well as in SAP-deficient
mouse models. These include impaired
Th2 cell cytokine production by CD4+
T cells and CD4+ T follicular helper (Tfh)
cell function, a near absence of NKT cells,reduced cytotoxicity of NK cells andCD8+
T cells, decreased antibody production,
and impaired reactivation-induced cell
death of T cells (Cannons et al., 2011).
The B cell defect observed in SAP-defi-
cient mice is mainly secondary to the
defect in T cells (Qi et al., 2008). Whether
or not the remaining defects result from
common molecular and cellular mecha-
nisms is still debated. Three papers in
this issue of Immunity help to bring clarity
to these questions (Dong et al., 2012;
Kageyama et al., 2012; Zhao et al., 2012).
SAP family members, including SAP,
EAT2, and ERT, act by modulating the
function of a family of receptors known
as the SLAM (signaling lymphocyte acti-
vation molecule) family of receptors. The
six members of SLAM family receptors
contain two or four extracellular Ig-like
domains and a signaling motif in their
cytoplasmic domain known as the immu-
noreceptor tyrosine-based switch motif(ITSM), which function by binding to SAP
family members. Except for 2B4, which
interacts with CD48, all the other SLAM
family receptors are activated through
homotypic interactions.
Because SAP is a small protein, com-
posed of a single Src homology-2 (SH2)
domain and a short C terminus, and
because the ITSM motif is similar to the
ITIM motif, it was initially thought that
SAP promoted cell activation through an
anti-inhibitory mechanism, by blocking
the interaction of SLAM family receptors
with SH2 domain containing phospha-
tases such as SHP-1, SHP-2, and SHIP-1
(Cannons et al., 2011; Dong et al., 2009;
Sayos et al., 1998). However, SAP can
also directly transduce activating signals
that are known to be important for SAP-
dependent IL-4 production by CD4+
T cells. For example, SAP binds the tyro-
sine kinase Fyn (Latour et al., 2001) as
well as PKC-q (Cannons et al., 2010). So36, June 29, 2012 ª2012 Elsevier Inc. 899
